Last reviewed · How we verify
recombinant 70-kD heat-shock protein
recombinant 70-kD heat-shock protein is a Biologic drug developed by Memorial Sloan Kettering Cancer Center. It is currently in Phase 1 development.
At a glance
| Generic name | recombinant 70-kD heat-shock protein |
|---|---|
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes (PHASE2)
- Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia (PHASE1, PHASE2)
- Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia (PHASE1)
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- recombinant 70-kD heat-shock protein CI brief — competitive landscape report
- recombinant 70-kD heat-shock protein updates RSS · CI watch RSS
- Memorial Sloan Kettering Cancer Center portfolio CI
Frequently asked questions about recombinant 70-kD heat-shock protein
What is recombinant 70-kD heat-shock protein?
recombinant 70-kD heat-shock protein is a Biologic drug developed by Memorial Sloan Kettering Cancer Center.
Who makes recombinant 70-kD heat-shock protein?
recombinant 70-kD heat-shock protein is developed by Memorial Sloan Kettering Cancer Center (see full Memorial Sloan Kettering Cancer Center pipeline at /company/memorial-sloan-kettering-cancer-center).
What development phase is recombinant 70-kD heat-shock protein in?
recombinant 70-kD heat-shock protein is in Phase 1.